From around January 2010 to July 2023, Michael Dole, MD, allegedly billed Medicare for more than $32.7 million for routinely testing more than 22 classes of drugs in urine specimens from nearly all his patients at his pain management practice, according to a Sept. 18 news release from the Justice Department.
Dr. Dole tested for these drugs despite a lack of documentation of use or suspicion of use, according to the release. He allegedly received more than $11.7 million in reimbursements and used the proceeds on personal expenses.
Dr. Dole is charged with one count of conspiracy to commit healthcare fraud and five counts of healthcare fraud.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
